James Mason
Names
Identifer
Contact
Affiliations
-
University of Warwick, Warwick Medical School
- http://www2.warwick.ac.uk/fac/med/
- location: Coventry
Research profile
author of:
- The DH register of cost-effectiveness studies: a review of study content and quality (RePEc:chy:respap:128chedp)
by James Mason & Mike Drummond - Screening for diabetic retinopathy by optometrists: effectiveness and cost-effectiveness (RePEc:chy:respap:137chedp)
by James Mason & Mike Drummond - NICEly does it: economic analysis within evidence-based clinical practice guidelines (RePEc:chy:respap:164chedp)
by James Mason & Martin Eccles & Nick Freemantle & Mike Drummond - Evaluating change in professional behaviour: issues in design and analysis (RePEc:chy:respap:171chedp)
by Nick Freemantle & John Wood & James Mason - Topical preparations for the treatment of psoriasis in primary care: a systematic review (RePEc:chy:respap:41cheop)
by James Mason & Anne Mason & Michael Cork - Optometrist prescribing of therapeutic agents: economic implications for the UK (RePEc:chy:respap:43cheop)
by Anne Mason & James Mason - Cost-effectiveness league tables: think of the fans (RePEc:eee:hepoli:v:31:y:1995:i:3:p:231-238)
by Drummond, Michael & Mason, James & Torrance, George - Biotechnology: a special case for health technology assessment? (RePEc:eee:hepoli:v:41:y:1997:i:1:p:73-81)
by Mason, James & Drummond, Michael - A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines (RePEc:eee:hepoli:v:47:y:1999:i:1:p:37-52)
by Mason, James & Eccles, Martin & Freemantle, Nick & Drummond, Michael - Optometrist prescribing of therapeutic agents: findings of the AESOP survey (RePEc:eee:hepoli:v:60:y:2002:i:2:p:185-197)
by Mason, Anne & Mason, James - Cost-effectiveness league tables: More harm than good? (RePEc:eee:socmed:v:37:y:1993:i:1:p:33-40)
by Drummond, Michael & Torrance, George & Mason, James - Creating ‘therapeutic landscapes’ for mental health carers in inpatient settings: A dynamic perspective on permeability and inclusivity (RePEc:eee:socmed:v:91:y:2013:i:c:p:122-129)
by Wood, Victoria J. & Curtis, Sarah E. & Gesler, Wil & Spencer, Ian H. & Close, Helen J. & Mason, James & Reilly, Joe G. - Spaces for smoking in a psychiatric hospital: Social capital, resistance to control, and significance for ‘therapeutic landscapes’ (RePEc:eee:socmed:v:97:y:2013:i:c:p:104-111)
by Wood, Victoria J. & Curtis, Sarah E. & Gesler, Wil & Spencer, Ian H. & Close, Helen J. & Mason, James M. & Reilly, Joe G. - Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards (RePEc:eee:socmed:v:97:y:2013:i:c:p:201-209)
by Curtis, Sarah & Gesler, Wilbert & Wood, Victoria & Spencer, Ian & Mason, James & Close, Helen & Reilly, Joseph - Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials (RePEc:plo:pone00:0082694)
by James M Mason & Kim S Thomas & Angela M Crook & Katharine A Foster & Joanne R Chalmers & Andrew J Nunn & Hywel C Williams - Agreement between gastrointestinal panel testing and standard microbiology methods for detecting pathogens in suspected infectious gastroenteritis: Test evaluation and meta-analysis in the absence of (RePEc:plo:pone00:0173196)
by Karoline Freeman & Alexander Tsertsvadze & Sian Taylor-Phillips & Noel McCarthy & Hema Mistry & Rohini Manuel & James Mason - Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data (RePEc:sae:medema:v:41:y:2021:i:6:p:667-684)
by Felix Achana & Daniel Gallacher & Raymond Oppong & Sungwook Kim & Stavros Petrou & James Mason & Michael Crowther - The Importance of Achieving Additional Drug Benefits at a Reasonable Cost (RePEc:spr:pharme:v:17:y:2000:i:4:p:319-324)
by Nick Freemantle & James Mason - Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Sys (RePEc:spr:pharme:v:35:y:2017:i:5:d:10.1007_s40273-016-0485-x)
by Melina Dritsaki & Felix Achana & James Mason & Stavros Petrou - Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal (RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-017-0599-9)
by Hema Mistry & Chidozie Nduka & Martin Connock & Jill Colquitt & Theodoros Mantopoulos & Emma Loveman & Renata Walewska & James Mason - Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal (RePEc:spr:pharme:v:37:y:2019:i:6:d:10.1007_s40273-019-00773-w)
by Hema Mistry & Chidozie Nduka & Martin Connock & Jill Colquitt & Theodoros Mantopoulos & Emma Loveman & Renata Walewska & James Mason - The urgent case for stronger climate targets for international shipping (RePEc:taf:tcpoxx:v:22:y:2022:i:3:p:301-309)
by Simon Bullock & James Mason & Alice Larkin - Reporting guidelines for economic studies (RePEc:wly:hlthec:v:4:y:1995:i:2:p:85-94)
by James Mason & Michael Drummond - Student corner (RePEc:wly:hlthec:v:5:y:1996:i:4:p:375-379)
by James Mason